Drug intelligence / Profile preview

Qudu Zengning

Development stage
Unknown
Lead developer
Beijing Shijikang Pharmaceutical Technology Development
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Qudu Zengning is a traditional Chinese medicine (TCM) capsule formulation containing extracts from four Chinese medicinal herbs. It has been studied primarily for the treatment of HIV/AIDS patients with Qi and Yin deficiency and internal heat syndrome. Clinical studies involving over 1,000 AIDS patients have shown that treatment with Qudu Zengning improved symptoms in most patients, increased CD4 cell counts significantly (from an average of 115.0 to 295.2/μl), and reduced or stabilized viral load after six months of therapy. The mechanism is not fully elucidated but is presumed to involve immunomodulation and support of immune reconstruction in HIV-infected individuals[1][2].

Brand names
Qudu Zengning袪毒增宁胶囊
Other names
QuDu ZengNing Capsule祛毒增宁胶囊

Beyond the preview

Go deeper on Qudu Zengning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qudu Zengning.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call